Digestive

GSK, Pfizer to merge consumer health businesses
GlaxoSmithKline will have a controlling 68% equity interest and Pfizer will have a 32% equity interest in the joint venture, which would have a global OTC market share of 7.3%, leading the market in most key geographical areas, including the United States and China.
RB, Walmart and Doctor on Demand partner on promotion
This fall, Walmart shoppers who buy such RB brands as Mucinex, Delsym, Airborne or Digestive Advantage online or in-store will receive a limited-time offer for a no-cost Doctor on Demand consultation.

Media buys or jingles: What wins antacid sales?

Alphonso’s TS Kelly takes a look at how OTC heartburn makers grab share of mind and dollars through strategic ad buys.
FDA clears Perrigo’s store-brand Imodium Multi-Symptom Relief

The approval, announced Friday, allows Perrigo to launch the product in the fourth quarter of the year, which the company said it was planning.
Neosanté marks National Breastfeeding Awareness Month

The Boca Raton, Fla.-based maker of Delictase Oral Drops noted that colic often accompanies breastfeeding, potentially leading to irritability, agitation and crying.
Dr. Reddy’s launches OTC generic Nexium 24 hour capsules

Dr. Reddy’s Laboratories has received the Food and Drug Administration’s nod for an over-the-counter generic version of AstraZeneca’s Nexium 24 hour capsules (esomeprazole magnesium delayed-release capsules) in a 20-mg dosage strength.
Renew Life Ultimate Flora Probiotics goes non-GMO, organic

The new Renew Life line of organic products incorporates a certified organic XOS source that is gentle and well tolerated, the Oakland, Calif.-based company reported.
Reliefband Technologies to kick off National Stop Nausea Day

To kick off the first National Stop Nausea Day on May 15, 2018 — Reliefband has partnered with Carmel, a popular New York-based car service.
Somna Therapeutics' Reflux Band now available OTC

The Reflux Band, formerly known as the Reza Band, helps reduce or eliminate laryngopharyngeal reflux symptoms.
FDA rules active in MiraLax can only be marketed as OTC

FDA's decision impacts five manufacturers with PEG 3350 ANDA approvals, including Kremers Urban Pharmaceuticals, Breckenridge Pharmaceutical, Nexgen Pharma, Paddock Laboratories and Teva Pharmaceutical.

GSK, Pfizer to merge consumer health businesses

RB, Walmart and Doctor on Demand partner on promotion

Media buys or jingles: What wins antacid sales?

FDA clears Perrigo’s store-brand Imodium Multi-Symptom Relief

Neosanté marks National Breastfeeding Awareness Month

Dr. Reddy’s launches OTC generic Nexium 24 hour capsules

Renew Life Ultimate Flora Probiotics goes non-GMO, organic

Reliefband Technologies to kick off National Stop Nausea Day

Somna Therapeutics' Reflux Band now available OTC

FDA rules active in MiraLax can only be marketed as OTC